by allergytalk
AllergyTalk is a round-up of the latest in the field of allergy and immunology by the American College of Allergy, Asthma & Immunology. In each bi-monthly episode, hosts Gerald Lee, MD and Stanley Fineman, MD invite a guest to discuss key articles reviewed in the current issue of AllergyWatch.
Language
🇺🇲
Publishing Since
5/15/2019
Email Addresses
0 available
Phone Numbers
0 available
March 25, 2025
Today we are joined by Dr. Iris Otani, an associate professor of medicine at UCSF and an assistant editor of Allergy Watch. We will be reviewing the November-December 2024 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. For information about CME credit, head over to http://education.acaai.org/allergytalk To read archived issues of AllergyWatch, head over to http://college.acaai.org/publications/allergywatch Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles! Articles Reviewed: Frequencies and predictors of subcutaneous and intraosseous injection with 4 epinephrine autoinjector devices. Forecasting daily total pollen concentrations on a global scale. Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis. Please rate our podcast on Apple Podcasts! Please give us feedback, corrections, and suggestions! Email feedback to: [email protected] ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
March 11, 2025
Today we are joined by Dr. Iris Otani, an associate professor of medicine at UCSF and an assistant editor of Allergy Watch. We will be reviewing the November-December 2024 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. For information about CME credit, head over to http://education.acaai.org/allergytalk To read archived issues of AllergyWatch, head over to http://college.acaai.org/publications/allergywatch Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles! Articles Reviewed: Effect of Azithromycin on Asthma Remission in Adults With Persistent Uncontrolled Asthma: A Secondary Analysis of a Randomized, Double-Anonymized, Placebo-Controlled Trial. Polyethylene glycol hypersensitivity, patient outcomes in a 7-year retrospective study. Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity. Please rate our podcast on Apple Podcasts! Please give us feedback, corrections, and suggestions! Email feedback to: [email protected] ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
January 31, 2025
Welcome to Season Three of AllergyTalk! Today we are joined by Dr. Vivian Hernandez Trujillo, the Division Director of allergy/immunology at Nickalus Children’s Hospital and an assistant editor of Allergy Watch. We will be reviewing the July-August issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. For information about CME credit, head over to http://education.acaai.org/allergytalk To read archived issues of AllergyWatch, head over to http://college.acaai.org/publications/allergywatch Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles! Articles Reviewed: The mental health burden of food allergies: Insights from patients and their caregivers from the Food Allergy Research & Education (FARE) Patient Registry. Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders. Bronchoconstriction damages airway epithelia by crowding-induced excess cell extrusion. Please rate our podcast on Apple Podcasts! Please give us feedback, corrections, and suggestions! Email feedback to: [email protected] ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced. Today’s speakers have the following disclosures: Dr. Lee has been a speaker for Novartis Dr. Fineman has nothing to disclose Dr. Hernandez Trujillo: Advisory Board: Aimmune, ARS, Bryn, Bayer, Enzyvant, Pfizer, Sanofi & Regeneron, Takeda Consultant: Pharming, Kaleo Speaker: CSL, Takeda, Kaleo
Journal of Allergy and Clinical Immunology: In Practice (JACI)
The American Academy of Allergy, Asthma & Immunology (AAAAI)
New York Times Opinion
The Free Press
Dr. Becky Kennedy
Dr. Cathryn
CSACI
Dr. Jim Dahle of the White Coat Investor
Dr. Mark Hyman
Hidden Brain, Shankar Vedantam
The New York Times
ChooseFI
Peter Kim, MD
Glennon Doyle and Audacy
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.